Pages
Wellbeing support across Joined Up Care Derbyshire - New Spring activity timetable for 2023 is here!
Patient Group Directions (PGDs)
Patient Group Directions - PGDs provide a legal framework that allows some registered health professionals to supply and/or administer a specified medicine(s) to a pre-defined group of patients, without them having to see a prescriber.
Flu – make your informed CHOICE
All the information about this year's flu vaccination programme, Covid booster jabs and winter wellbeing found here!
Community nursing practitioners network
New national network for community nursing practitioners. The network has been set up for sharing of information and connecting community practitioners.
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/community-nursing-practitioners-network
Storm Henk – update and advice
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/storm-henk-update-and-advice
Message from Michelle Bateman - Registered Nursing Associates
An update from Michelle about how DCHS has supported the Nursing Associate role since 2019.
Files
PAT Procedure
PAT Procedure
DCHS Tissue Viability Non-Concordance guidelines and Pathway (G309)
DCHS Tissue Viability Non-Concordance guidelines and Pathway
ICS Catheter Clinic Guidance (G324)
ICS Catheter Clinic Guidance
Policy template FINAL (DCHS Policy Development Framework)
Policy template FINAL (DCHS Policy Development Framework)
Disclosure Ref 2024135 - No. of Datix Incidents Involving Patient Misidentification.pdf
FOI Disclosure Ref 2024135 regarding number of Datix Incidents Involving Patient Misidentification
Disclosure Ref 2024128 - Social Media Platforms.pdf
FOI Disclosure Ref 2024128 - Social Media Platforms
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates.pdf
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010
A1 - Observational Audit - protected meal times (G50)
Observational Audit - protected meal times
Integrated Performance Report - November 2024
Integrated Performance Report - November 2024